Published 2 February 2009, doi:10.1136/bmj.b384
Cite this as: BMJ 2009;338:b384
Letters
Conflicting recommendations
Checklist for guidelines
| The first 150 words of the full text of this article appear below. |
Perhaps it is time to develop a standardised document for developing guidelines that includes these points.1
- Which group—individuals, association—called for the development of the guidelines?
- Are they new? If so, why are they being developed?
- Are they an update? If so, why is the update important?
- Do the guidelines revise diagnostic criteria against the old ones? Why?
- Do the new diagnostic criteria differ from those being used in other countries/regions? If so, how and why are the new ones an improvement?
- Are the treatment guidelines different?
- Has there been any new drug launched that is somehow coincidental with the development of new treatment guidelines? Are there any associations between those who revised them and the new drug?
- Names of all parties and groups involved in the development, writing, publication, and dissemination of new guidelines, including funding.
There should also perhaps be a central repository for all treatment guidelines with an . . . [Full text of this article]
Joan McClusky, medical writer1
1 New York, NY 10003, USA

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
What should clinicians do when faced with conflicting recommendations?
- Andrew D Oxman, Paul Glasziou, and John W Williams, Jr
BMJ 2008 337: a2530.
[Extract]
[Full Text]